Analyze Diet

Topic:Pharmacokinetics

Pharmacokinetics in horses involves the study of how drugs are absorbed, distributed, metabolized, and excreted in equine species. This field of study provides insights into the time course of drug concentrations within the horse's body and helps in understanding the effects of various pharmaceuticals. Key parameters in equine pharmacokinetics include absorption rates, bioavailability, half-life, and clearance. These parameters can vary significantly due to factors such as age, breed, and health status of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the pharmacokinetic profiles of different drugs in horses, aiming to optimize dosing regimens and improve therapeutic outcomes in equine medicine.
Inhibition and inactivation of equine aromatase by steroidal and non-steroidal compounds. A comparison with human aromatase inhibition.
Journal of enzyme inhibition    March 21, 1998   Volume 12, Issue 4 241-254 doi: 10.3109/14756369709035817
Moslemi S, Seralini GE.In order to approach the detailed structure-function relationships of aromatase, we studied the inhibitory and inactivatory potencies of several steroidal androstenedione analogues (1: 4-hydroxyandrostenedione, 2: 4-acetoxyandrostenedione and 3: 7 alpha-(4'-amino)phenylthio-4-androstene-3, 17-dione) and non-steroidal imidazole derivatives (4: ketoconazole, 5: miconazole and 6: fadrozole) on equine aromatase in placental microsomes, a well established mammalian model. Human placental microsomes and the purified enzyme from equine testis were also used to compare inhibition by 1 and 2. In equine...
A toxicity study of eltenac, a nonsteroidal anti-inflammatory drug, in horses.
Journal of veterinary pharmacology and therapeutics    March 21, 1998   Volume 21, Issue 1 24-33 doi: 10.1046/j.1365-2885.1998.00813.x
Goodrich LR, Furr MO, Robertson JL, Warnick LD.A double-blind study was performed, in horses, to determine the potential toxic effects of the nonsteroidal anti-inflammatory drug, eltenac(4-[(2,6-dichlorophenyl) amino]-3-thiopheneacetic acid). Four treatment groups of six horses were formed. The drug was injected intravenously, once daily, at a dose level of 0.5 mg/kg, 1.5 mg/kg or 2.5 mg/kg for 15 days. A control group was injected with sterile saline solution. Horses were monitored for changes in appetite, physical examinations, biochemical evaluations and gastroscopic examinations. Complete post-mortem examinations were also performed. A...
Uptake of drugs from topically applied anti-inflammatory preparations applied to racing animals.
Australian veterinary journal    February 20, 1998   Volume 75, Issue 12 897-901 doi: 10.1111/j.1751-0813.1997.tb11261.x
Thomas AD, Bowater IC, Vine JH, McLean JG.To determine whether a drug detected in the blood or urine of a racing animal could have penetrated through the skin from a topically applied preparation. Methods: Blood and urine of dogs and horses were analysed after topical administration of three common nonsteroidal anti-inflammatory preparations. Methods: Dimethylsulphoxide was analysed using a gas chromatograph with a flame photometric detector. Phenylbutazone, its metabolites and lignocaine were analysed using a gas chromatograph with a mass selective detector. Results: Dimethylsulphoxide, phenylbutazone and lignocaine were detected in ...
Pharmacokinetics and cardiopulmonary effects of guaifenesin in donkeys.
Journal of veterinary pharmacology and therapeutics    February 7, 1998   Volume 20, Issue 6 442-446 doi: 10.1046/j.1365-2885.1997.00081.x
Matthews NS, Peck KE, Mealey KL, Taylor TS, Ray AC.Five donkeys and three horses were given guaifenesin, intravenously, by gravity administration, until recumbency was produced. The time and dose required to produce recumbency, recovery time to sternal and standing were recorded. Blood samples were collected for guaifenesin assay at 10, 20, 30, 40, 50, 60 min, and 2, 3, 4 and 6 h after guaifenesin administration. Serum was analysed for guaifenesin using HPLC and pharmacokinetic values were calculated using a computer software package (RSTRIP). In donkeys, heart and respiratory rates and blood pressures were recorded before and at 5-min interva...
Plasma pharmacokinetics of ranitidine HCl in foals.
Journal of veterinary pharmacology and therapeutics    February 7, 1998   Volume 20, Issue 6 447-452 doi: 10.1046/j.1365-2885.1997.00093.x
Holland PS, Brumbaugh GW, Ruoff WW, Brown SA.Plasma pharmacokinetics of ranitidine HCl were investigated after intravenous (i.v.) and oral (p.o.) administration of drug to six healthy foals. Twelve- to sixteen-week-old foals received 2.2 mg ranitidine/kg i.v. and 4.4 mg ranitidine/kg p.o. Concentrations of ranitidine were determined using normal phase high performance liquid chromatography. Plasma concentrations of ranitidine HCl declined from a mean of 3266 ng/mL at 5 min to 11 ng/mL at 720 min after administration. The profile of the plot of concentrations of ranitidine HCl vs. time was best described by a two-exponent equation for two...
The pharmacokinetics of cefadroxil over a range of oral doses and animal ages in the foal.
Journal of veterinary pharmacology and therapeutics    February 7, 1998   Volume 20, Issue 6 427-433 doi: 10.1046/j.1365-2885.1997.00085.x
D○ NE, Stang BE, Schaeffer DJ.To evaluate the effect of foal age on the pharmacokinetics of cefadroxil, five foals were administered cefadroxil in a single intravenous dose (5 mg/kg) and a single oral dose (10 or 20 mg/kg) at ages of 0.5, 1, 2, 3 and 5 months. Pharmacokinetic parameters of terminal elimination rate constant (beta(po)), oral mean residence time (MRTpo), mean absorption time (MAT), rate constant for oral absorption (Ka), bioavailability F, peak serum concentrations (Cmax) and time of peak concentration (tmax), were evaluated in a repeated measures analysis over dose. Across animal ages, parameters for the in...
The effects of pentoxifylline infusion on plasma 6-keto-prostaglandin F1 alpha and ex vivo endotoxin-induced tumour necrosis factor activity in horses.
Journal of veterinary pharmacology and therapeutics    February 7, 1998   Volume 20, Issue 6 487-492 doi: 10.1046/j.1365-2885.1997.00090.x
Barton MH, Ferguson D, Davis PJ, Moore JN.Pentoxifylline (7.5 mg/kg) was bolused intravenously to eight healthy horses and was immediately followed by infusion (1.5 mg/kg/h) for 3 h. Clinical parameters were recorded and blood samples were collected for 24 h. Plasma was separated and concentrations of pentoxifylline, its reduced metabolite I, and 6-keto-prostaglandin F1 alpha were determined. Heparinized whole blood was also incubated ex vivo with 1 ng Escherichi coli endotoxin/mL blood for 6 h before determination of plasma tumour necrosis factor activity. The peak plasma concentrations of pentoxifylline and metabolite I occurred at ...
Role of oligosaccharides in the pharmacokinetics of tissue-derived and genetically engineered cholinesterases.
Molecular pharmacology    January 28, 1998   Volume 53, Issue 1 112-122 doi: 10.1124/mol.53.1.112
Saxena A, Ashani Y, Raveh L, Stevenson D, Patel T, Doctor BP.To understand the role of glycosylation in the circulation of cholinesterases, we compared the mean residence time of five tissue-derived and two recombinant cholinesterases (injected intravenously in mice) with their oligosaccharide profiles. Monosaccharide composition analysis revealed differences in the total carbohydrate, galactose, and sialic acid contents. The molar ratio of sialic acid to galactose residues on tetrameric human serum butyrylcholinesterase, recombinant human butyrylcholinesterase, and recombinant mouse acetylcholinesterase was found to be approximately 1.0. For Torpedo ca...
Evaluation of some parameters influencing the drug delivery from a dry powder inhalation device using an in vitro model of the horse airways.
Veterinary research    January 15, 1998   Volume 28, Issue 6 557-564 
Duvivier DH, Chiap P, Crommen J, Lekeux P.The aim of this study was to determine the effect of breathing pattern, air humidity and position of the device on the delivery of an aerosol generated by a dry powder inhalation (DPI) device (Inhalator M). The in vitro inhalation study was performed using the cascade impaction method (Andersen Sampler) adapted to imitate nasal breathing. The amount of ipratropium found in the device, the artificial upper airways and the six stages of the Andersen Sampler was measured using high precision liquid chromatography. Stage 1 of the Andersen Sampler was considered to be the respirable fraction and st...
Treatment of horses with phenylbutazone.
The Veterinary record    January 10, 1998   Volume 141, Issue 22 584 
Dyson S.No abstract available
Oxidant stress in the equine lung: response to oral prednisolone.
The Veterinary record    January 7, 1998   Volume 141, Issue 20 518-519 doi: 10.1136/vr.141.20.518
Mills PC, Roberts CA, Smith NC.No abstract available
Pharmacokinetics of cisapride in horses after intravenous and rectal administration.
American journal of veterinary research    December 24, 1997   Volume 58, Issue 12 1427-1430 
Cook G, Papich MG, Roberts MC, Bowman KF.To determine the i.v. pharmacokinetics of cisapride and measure systemic absorption after rectal administration. Methods: 5 healthy adult mares (380 to 610 kg). Methods: Cisapride was administered, i.v., at a dosage of 0.1 mg/kg of body weight. In the same horses, after a 1-week washout period, cisapride was administered rectally at a dosage of 1 mg/kg by mixing crushed tablets with propylene glycol and administering the mixture into the rectum. After each drug administration, a series of blood samples were collected. Plasma was obtained and analyzed by high-performance liquid chromatography t...
Clinical trial of moxidectin oral gel in horses.
Veterinary parasitology    December 24, 1997   Volume 72, Issue 2 167-177 doi: 10.1016/s0304-4017(97)01108-4
DiPietro JA, Hutchens DE, Lock TF, Walker K, Paul AJ, Shipley C, Rulli D.A clinical trial carried out over 98 days was done to evaluate treatment of horses with moxidectin gel for efficacy as measured by (1) reduction in the production of parasite ova post treatment, (2) a comparison of the posttreatment parasite egg count suppression of moxidectin to ivermectin, and (3) assessment of the field safety, animal acceptance of the moxidectin formulation, and the utility of the moxidectin delivery device. One hundred and fifty Standardbred horses with naturally acquired parasite infections were used in the study. Moxidectin had more prolonged and greater suppressive inf...
Inhaled medications and bronchodilator usage in the horse.
The Veterinary clinics of North America. Equine practice    November 22, 1997   Volume 13, Issue 3 519-530 doi: 10.1016/s0749-0739(17)30228-6
Hoffman AM.The advantages of aerosol medications include the direct, topical application to the target organ (airways); rapid effect; and low systemic availability. There are now more efficient methods for aerosol delivery that facilitate the use of increasingly sophisticated aerosol drugs. This article reviews the principles of aerosol deposition and the pharmacology of current medications.
Immune therapy in respiratory disease.
The Veterinary clinics of North America. Equine practice    November 22, 1997   Volume 13, Issue 3 531-548 doi: 10.1016/s0749-0739(17)30229-8
Rush BR.Pharmacologic manipulation of pulmonary immunity plays an important role in primary and adjunct therapy for equine respiratory disease. Frequent exposure to respiratory viral pathogens, strenuous exercise, long distance transport, and inhalation of harmful substances destroy various aspects of the pulmonary defense system and predispose performance horses to development of infectious and noninfectious respiratory disease. Pulmonary immunity may be bolstered by nonspecific immunostimulants to combat primary or secondary immunodeficiency. State of the art technology improves active and passive-s...
Use of carprofen in racehorses.
The Veterinary record    November 19, 1997   Volume 141, Issue 15 400 
Balmer T, Curwen A.No abstract available
Concentration of enrofloxacin in equine tissues after long-term oral administration.
Journal of veterinary pharmacology and therapeutics    November 14, 1997   Volume 20, Issue 5 402-404 doi: 10.1046/j.1365-2885.1997.00071.x
Giguère S, Bélanger M.No abstract available
Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone.
Journal of veterinary pharmacology and therapeutics    November 14, 1997   Volume 20, Issue 5 355-361 doi: 10.1046/j.1365-2885.1997.00083.x
Sams RA, Gerken DF, Dyke TM, Reed SM, Ashcraft SM.Cimetidine was administered intravenously and by the intragastric route to six mares at a dose of 4.0 mg/kg of body weight (bw). Specific and sensitive high performance liquid chromatographic methods for the determination of cimetidine in horse plasma and urine and cimetidine sulfoxide in urine are described. Plasma cimetidine concentration vs. time data were analysed by non-linear least squares regression analysis to determine pharmacokinetic parameter estimates. The median (range) plasma clearance (Cl) was 8.20 (4.96-10.2) mL/min.kg of body weight, that of the steady-state volume of distribu...
Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration.
Equine veterinary journal    November 5, 1997   Volume 29, Issue 5 378-381 doi: 10.1111/j.2042-3306.1997.tb03143.x
Kaartinen L, Panu S, Pyörälä S.Pharmacokinetic behaviour of enrofloxacin was studied in 6 horses after intravenous (i.v.) or intramuscular (i.m.) administration of enrofloxacin (5 mg/kg bwt). Concentration of enrofloxacin and ciproflaxin were measured by high performance liquid chromatography in serum. Antimicrobial activity of the samples was determined with an agar-diffusion technique. Reactions at the site of i.m. injection were monitored clinically and by determination of serum creatine kinase (CK) activity. After i.v. administration, elimination half-life of enrofloxacin was 4.4 h and volume of distribution was 2.3 1/k...
Effects of postoperative peritoneal lavage on pharmacokinetics of gentamicin in horses after celiotomy.
American journal of veterinary research    November 5, 1997   Volume 58, Issue 10 1166-1170 
Easter JL, Hague BA, Brumbaugh GW, Nguyen J, Chaffin MK, Honnas CM, Kemper DL.To evaluate the effect of peritoneal lavage on pharmacokinetics of gentamicin sulfate in healthy horses after experimental celiotomy. Methods: 13 clinically normal horses. Methods: Horses were randomly assigned to control or experimental groups. All horses received gentamicin (6.6 mg/kg of body weight, IV, q 24 h) before surgery, underwent experimental abdominal surgery, and had abdominal drains placed percutaneously. Horses of the experimental group received postoperative peritoneal lavage; horses of the control group did not receive peritoneal lavage. The day after surgery, 24 hours after th...
Brodifacoum toxicosis in two horses.
Journal of the American Veterinary Medical Association    October 23, 1997   Volume 211, Issue 7 882-886 
McConnico RS, Copedge K, Bischoff KL.Increased popularity during the past decade of brodifacoum, an anticoagulant rodenticide, has led to an increase in cases of accidental poisoning in nontarget species, including pets and farm animals. Pharmacokinetics of second-generation anticoagulant rodenticides such as brodifacoum are substantially different from those of first-generation anticoagulant rodenticides such as warfarin. This difference dramatically influences management of exposure in terms of duration and cost of treatment and may affect outcome. The National Poison Control Center reports that approximately 50 cases of brodif...
Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys.
American journal of veterinary research    August 1, 1997   Volume 58, Issue 8 881-884 
Peck K, Mealey KL, Matthews NS, Taylor TS.To determine whether clearance of capacity-limited drugs in horses differs from that in donkeys by comparing the serum disposition of caffeine and its metabolites, theophylline, theobromine, and paraxanthine after i.v. administration of caffeine to horses and donkeys. Methods: 4 healthy horses and 5 healthy donkeys. Methods: Blood samples were collected from each animal at time 0 (before) and 5, 10, 15, 20, 30, and 45 minutes, and 1, 2, 3, 4, 6, 8, 12, 24, 30, 36, 48, 54, 60, 72, and 96 hours after IV administration of a bolus of caffeine. Serum was analyzed in triplicate by high-performance l...
Disposition of flunixin after intramuscular administration of flunixin meglumine to horses.
Journal of veterinary pharmacology and therapeutics    August 1, 1997   Volume 20, Issue 4 330-332 doi: 10.1046/j.1365-2885.1997.00069.x
Dyke TM, Sams RA, Cosgrove SB.No abstract available
Age-related changes in the pharmacokinetic disposition of diazepam in foals.
American journal of veterinary research    August 1, 1997   Volume 58, Issue 8 878-880 
Norman WM, Court MH, Greenblatt DJ.To evaluate changes in the pharmacokinetic disposition of diazepam in foals from 4 to 84 days of age. Methods: 4 male and 2 female full-term mixed-breed foals. Methods: Diazepam terminal half-life, volume of distribution, clearance, free fraction, unbound volume of distribution, free clearance, peak desmethyldiazepam concentration, and area under the desmethyldiazepam concentration-time curve were determined after i.v. administration of 0.25 mg of diazepam/kg of body weight to foals at 4, 21, 42, and 84 days of age. Results: Disposition of diazepam was best described using a two-compartment mo...
Pharmacology of the 5-lipoxygenase inhibitors BAY Y 1015 and BAY X 1005 in the horse.
Journal of veterinary pharmacology and therapeutics    August 1, 1997   Volume 20, Issue 4 296-307 doi: 10.1046/j.1365-2885.1997.00064.x
Cunningham FM, Andrews M, Landoni MF, Lees P.Calcium ionophore A23187 induced time and concentration dependent production of immunoreactive leukotriene (LT) B4 by equine heparinized whole blood in vitro. Time dependent production of immunoreactive LTB4 by equine neutrophils and immunoreactive LTC4 by equine eosinophils in vitro was also demonstrated. The 5-lipoxygenase activating protein (FLAP) inhibitors, BAY X 1005 and BAY Y 1015, produced concentration dependent inhibition of ionophore-induced LTB4 synthesis by equine whole blood (mean +/- SEM IC50s n = 5; 6.14 +/- 0.28 microM vs. 12.30 +/- 0.75 microM for BAY Y 1015 and BAY X 1005, r...
The effect of the acute-phase response on in vitro drug metabolism and plasma protein binding in the horse.
Veterinary research communications    July 1, 1997   Volume 21, Issue 5 361-368 doi: 10.1023/a:1005816422279
Mills PC, Ng JC, Auer DE.The effect of the acute-phase response (APR) on the activity of the hepatic drug-metabolizing system (DMS) and on the binding of phenylbutazone to plasma proteins was investigated in the horse. An APR was induced by intramuscular injections of Freund's complete adjuvant in five horses and, five days later, these horses together with five clinically normal horses were shot and the right ventral lobe of each liver removed. The hepatic microsomal fractions from the liver samples were isolated and significantly lower (p < 0.01) concentrations of cytochromes P450 and b5 and activities of aniline...
Determination of methocarbamol in equine serum and urine by high-performance liquid chromatography with ultraviolet detection and atmospheric pressure ionization-mass spectrometric confirmation.
Journal of analytical toxicology    July 1, 1997   Volume 21, Issue 4 301-305 doi: 10.1093/jat/21.4.301
Koupai-Abyazani MR, Esaw B, Laviolette B.Urine and serum samples collected from four standard-bred mares after and oral regimen administration of methocarbamol were extracted and analyzed. The method consisted of enzyme hydrolysis followed by a one-step liquid-liquid extraction, separation on a reversed-phase (RP-18) column, and detection using an ultraviolet (UV) detector. The confirmation was carried out using a liquid chromatography-atmospheric pressure ionization-mass spectrometry (LC-API-MS) system. Maximum methocarbamol concentrations of 1498, 1734, 1547, 2322 micrograms/mL in urine and 4.9, 1.7, and 3.6 micrograms/mL in serum ...
Anesthetic potency of desflurane in the horse: determination of the minimum alveolar concentration.
Veterinary surgery : VS    July 1, 1997   Volume 26, Issue 4 354-357 doi: 10.1111/j.1532-950x.1997.tb01511.x
Tendillo FJ, Mascías A, Santos M, López-Sanromán J, De Rossi R, San Román F, Gómez de Segura IA.To determine the minimum alveolar concentration (MAC) of desflurane (DES) in the horse. Methods: Prospective study. Methods: Six healthy adult horses (three males and three females) weighing 370 +/- 16 kg and aged 9 +/- 2 years old. Methods: Anesthesia was induced with DES vaporized in oxygen via a face mask connected to a large-animal, semiclosed anesthetic circle system. The horses were endotracheally intubated and positioned in right lateral recumbency. Inspired and end-tidal DES were monitored using a calibrated Ohmeda RGM 5250 multigas analyzer (Ohmeda-BOC, Spain). The MAC of desflurane t...
Structure of glycan moieties responsible for the extended circulatory life time of fetal bovine serum acetylcholinesterase and equine serum butyrylcholinesterase.
Biochemistry    June 17, 1997   Volume 36, Issue 24 7481-7489 doi: 10.1021/bi963156d
Saxena A, Raveh L, Ashani Y, Doctor BP.Cholinesterases are serine hydrolases that can potentially be used as pretreatment drugs for organophosphate toxicity, as drugs to alleviate succinylcholine-induced apnea, and as detoxification agents for environmental toxins such as heroin and cocaine. The successful application of serum-derived cholinesterases as bioscavengers stems from their relatively long residence time in the circulation. To better understand the relationship between carbohydrate structure and the stability of cholinesterases in circulation, we determined the monosaccharide composition, the distribution of various oligo...
Use of yohimbine to reverse prolonged effects of xylazine hydrochloride in a horse being treated with chloramphenicol.
Journal of the American Veterinary Medical Association    June 15, 1997   Volume 210, Issue 12 1771-1773 
Grubb TL, Muir WW, Bertone AL, Beluche LA, Garcia-Calderon M.A 1-year-old Standardbred gelding had received xylazine hydrochloride (0.75 to 1.00 mg/kg [0.34 to 0.45 mg/lb] of body weight, IV) during 2 surgeries for debridement of a wound. The horse was given chloramphenicol (55 mg/kg [25 mg/lb], PO, q 6 h) for 5 days, and was anesthetized a third time with xylazine (0.75 mg/kg, IM). Five hours after administration of xylazine, the horse remained markedly sedated and had clinical signs of gaseous distention of the large bowel (bloat) requiring trocharization. Administration of yohimbine (0.03 mg/kg [0.01 mg/lb], i.v.) eliminated signs of sedation within ...
1 57 58 59 60 61 97